This was a retrospective study of 41 HIV-infected individuals from the HIV Neurobehavioral Research Center (HNRC)’s Prospective Memory cohort [11 (link)]. At the time of sampling, all participants were on ART with undetectable levels of HIV RNA in blood (<50 copies/μL of plasma; Amplicor HIV Monitor Test, Roche Molecular Systems Inc.). Blood lymphocyte profiles were obtained by flow-cytometry (CLIA certified local laboratories). Epidemiological, behavioral risk and clinical data were also collected from participants [12 (link)]. Individuals were deemed to have AIDS if they met Centers for Disease Control criteria (http://www.aidsmap.com/CDC-case-definitions/page/1391604/). The estimated duration of infection (EDI) was determined using results of serologic and virologic tests as described previously [13 (link)]. Paired stored CSF and blood samples were retrospectively selected and used for measurements of CSF and blood plasma markers of inflammation and cell-free mitochondrial DNA.